Dermatology · Garden City, NY
NPI
1518965441
Since 2005
Specialty
Dermatology
Code 173000000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
901 Stewart Ave, Suite 201
Garden City, NY, 11530
Phone (516) 227-3377
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
23,869 services
Medicare patients, 2024
1,217
Average age 74
Drug cost, 2024
$731K
2,859 prescriptions
Company payments, 2025
$39K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Theodore J Daly was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 11,402 times for 31 patients. In total Theodore J Daly billed 23,869 services in 95 codes, and Medicare paid $1.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 11,402 | 31 | $1.34 | $15K |
| 96922 Skin | Office | 1,862 | 88 | $217.93 | $406K |
| 99213 Office E&M - Established | Office | 1,651 | 843 | $78.48 | $130K |
| 17003 Destruction Skin Lesion | Office | 1,539 | 201 | $6.32 | $9,723 |
| 95044 Test - Miscellaneous | Office | 1,051 | 13 | $5.08 | $5,337 |
| 17110 Destruction Skin Lesion | Office | 736 | 448 | $94.92 | $70K |
| 99214 Office E&M - Established | Office | 728 | 405 | $110.92 | $81K |
| 17004 Destruction Skin Lesion | Office | 457 | 264 | $154.27 | $71K |
| 96921 Skin | Office | 433 | 14 | $160.95 | $70K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 409 | 134 | $0.76 | $312 |
| 17000 Destruction Skin Lesion | Office | 388 | 273 | $39.57 | $15K |
| 11102 Skin Biopsy | Office | 324 | 256 | $67.69 | $22K |
| 17111 Destruction Skin Lesion | Office | 292 | 190 | $121.58 | $36K |
| 17360 Skin | Office | 247 | 67 | $105.92 | $26K |
| 96920 Skin | Office | 221 | 12 | $143.22 | $32K |
By year: 2022 $975K for 9,500 services; 2023 $1.1M for 12,444 services; 2024 $1.2M for 23,869 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 165 | 100 | $61.70 | $10K |
| 88311 Surgical Pathology Examination | 20 | 20 | $19.31 | $386 |
| 88312 Surgical Pathology Examination | 20 | 20 | $108.20 | $2,164 |
| 88313 Surgical Pathology Examination | 20 | 20 | $80.39 | $1,608 |
| 87101 General Laboratory | 14 | 12 | $7.56 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug Theodore J Daly prescribed most often to Medicare patients was Minoxidil, with 822 prescriptions and refills. In total Theodore J Daly wrote 2,859 Medicare prescriptions that cost $731K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 822 | 2,176 | 299 | $8,603 |
| Spironolactone Generic | 435 | 1,194 | 175 | $5,031 |
| Finasteride Generic | 208 | 598 | 92 | $3,001 |
| Dutasteride Generic | 198 | 530 | 70 | $6,167 |
| Clobetasol Propionate Generic | 114 | 129 | 61 | $5,260 |
| Halobetasol Propionate Generic | 77 | 79 | 68 | $4,048 |
| Tretinoin Generic | 70 | 78 | 49 | $4,371 |
| Tacrolimus Generic | 70 | 73 | 23 | $13K |
| Ketoconazole Generic | 62 | 64 | 34 | $665 |
| Opzelura Ruxolitinib Phosphate | 55 | 63 | 24 | $169K |
| Fluocinonide Generic | 34 | 36 | 27 | $1,497 |
| Zoryve Roflumilast | 33 | 35 | 11 | $29K |
| Triamcinolone Acetonide Generic | 32 | 36 | 22 | $1,601 |
| Levocetirizine Dihydrochloride Generic | 30 | 70 | 18 | $677 |
| Jublia Efinaconazole | 27 | 29 | 11 | $37K |
Brand drugs: - claims; generic drugs: 2,548 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Theodore J Daly $39K ($39K in general payments such as food, travel and fees) from 19 companies. The largest payer was Pfizer Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 25 | $21K |
| E.R. Squibb & Sons, L.L.C. BMY | 21 | $7,252 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 21 | $5,300 |
| Arcutis Biotherapeutics, Inc. ARQT | 10 | $3,677 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $395 |
| Abbvie Inc. ABBV | 16 | $263 |
| Galderma Laboratories, L.P. GALD.SW | 20 | $259 |
| LEO Pharma Inc. | 5 | $120 |
| Journey Medical Corporation DERM | 1 | $101 |
| Amgen Inc. AMGN | 4 | $87.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.